LFG
SNDX icon

Larson Financial Group’s Syndax Pharmaceuticals SNDX Stock Holding History

Larson Financial Group’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$60.6K Buy
2,594
+224
+9% +$4.87K ﹤0.01% 1250
2025
Q4 		$49.8K Sell
2,370
-552
-19% -$9.63K ﹤0.01% 1228
2025
Q3 		$45K Buy
2,922
+1,922
+192% +$25.2K ﹤0.01% 1206
2025
Q2 		$9.37K Sell
1,000
-24
-2% -$264 ﹤0.01% 1834
2025
Q1 		$12.6K Buy
1,024
+24
+2% +$339 ﹤0.01% 1549
2024
Q4 		$13.2K Hold
1,000
– – ﹤0.01% 1384
2024
Q3 		$19.3K Buy
+1,000
New +$20.7K ﹤0.01% 1230

Other funds holding SNDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Larson Financial Group's SNDX Position: Q1 2026 in Review

Larson Financial Group increased its Syndax Pharmaceuticals (SNDX) stake by 9.5% in Q1 2026, buying an estimated $4.87K and bringing the position to 2,594 shares worth $60.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1250.

Larson Financial Group first reported a position in SNDX in Q3 2024 and has held it in 7 quarters since. 246 funds tracked by Wall St. Rank hold SNDX as of Q1 2026.

  • Larson Financial Group held 2,594 shares of Syndax Pharmaceuticals worth $60.6K as of Q1 2026.
  • Larson Financial Group bought 224 Syndax Pharmaceuticals shares in Q1 2026, an estimated $4.87K.
  • Syndax Pharmaceuticals made up ﹤0.01% of Larson Financial Group's portfolio in Q1 2026, its #1250 holding.
  • Larson Financial Group first reported a position in Syndax Pharmaceuticals in Q3 2024 and has held it in 7 quarters since.
  • 246 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.